InVitria launches Optibumin® 25, the first recombinant 25% rHSA for closed-system use, enabling safer, scalable ...

A Wuhan-based biopharmaceutical company developed technology to synthesize human serum albumin (HSA) from rice, offering a potential solution to China's supply shortage of this critical blood protein.

Albumin is the most common type of protein in your blood, making up about half of the total proteins found in your blood plasma. Albumin is produced in your liver and is mostly stored and used in ...

Despite the market punishing Grifols, we believe that this presents a buying opportunity. Click here for our investment ...

When the stock markets in Hong Kong and mainland China resumed trading after a long weekend on Monday, traders knew they were in for a world of pain. Only a few niche healthcare companies emerged ...

A teacher from Sherborne who receives a medicine made from the plasma in blood donations is supporting the ongoing NHS appeal ...

On the front line of the tit-for-tat tariff fight between the US and China, Australian companies are trying to find a way to play both sides.